Optimization of the preparation of nalmefene-loaded sustained-release microspheres using central composite design

被引:29
作者
Wu, Xiang-Gen
Li, Gao
Gao, Yong-Liang
机构
[1] Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Wuhan 430030, Peoples R China
[2] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China
关键词
nalmefene; poly(lactic-co-glycolic acid); microsphere; central composite design-response surface methodology;
D O I
10.1248/cpb.54.977
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nalmefene-loaded poly(lactic-co-glycolic acid) microspheres were prepared by 0/0 emulsification/solvent evaporation method. The central composite design-response surface methodology was used to optimize and predict the preparation microspheres. Effects of three independent variable variables i.e., Span80 concentration in outer phase, poly(lactic-co-glycolic acid) concentration in inner phase and theoretical drug content were evaluated on a number of response variables. Response variables selected in this study were drug content, encapsulation efficiency, mean diameter, diameter span and the cumulative percentage of the drug released in the first day after incubation (marked as F-1d, and it was also calculated as the initial burst). Multiple linear regression and second-order polynomial model were fitted to the data, and the resulting equations were used to produce five dimensional response graphs, by which optimal experimental conditions were selected. The results showed that all response variables were greatly dependent on three independent variables, and the optimal conditions were Span80 concentration 1.5%, poly(lactic-co-glycolic acid) concentration 17.5%, and theoretical drug content 6%. According to the optimal conditions, the drug content, encapsulation efficiency, mean diameter, diameter span and F-1d of prepared microspheres were 4.37%, 72.8%, 64.1 mu m, 1.36 and 8.93%, respectively.
引用
收藏
页码:977 / 981
页数:5
相关论文
共 26 条
[1]   Preparation and evaluation of zidovudine-loaded sustained-release microspheres .2. Optimization of multiple response variables [J].
AbuIzza, K ;
GarciaContreras, L ;
Lu, DR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (06) :572-576
[2]   Preparation and evaluation of sustained release AZT-loaded microspheres: Optimization of the release characteristics using response surface methodology [J].
AbuIzza, MA ;
GarciaContreras, L ;
Lu, DR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (02) :144-149
[3]   Vivitrex®, an injectable, extended-release formulation of naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for 1 month in rats [J].
Bartus, RT ;
Emerich, DF ;
Hotz, J ;
Blaustein, M ;
Dean, RL ;
Perdomo, B ;
Basile, AS .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (11) :1973-1982
[4]  
CECILIA S, 1991, INT J PHARM, V89, P235
[5]   DETERMINATION OF NALMEFENE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION AND ITS APPLICATION IN PHARMACOKINETIC STUDIES [J].
CHOU, JZ ;
ALBECK, H ;
KREEK, MJ .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 613 (02) :359-364
[6]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[7]   Implantable technology for long-term delivery of nalmefene for treatment of alcoholism [J].
Costantini, LC ;
Kleppner, SR ;
McDonough, J ;
Azar, MR ;
Patel, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 283 (1-2) :35-44
[8]   Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method [J].
Cui, F ;
Cun, DM ;
Tao, AJ ;
Yang, MS ;
Shi, K ;
Zhao, M ;
Guan, Y .
JOURNAL OF CONTROLLED RELEASE, 2005, 107 (02) :310-319
[9]   Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration -: Effect of Labrafil addition on release in vitro [J].
Fernández-Carballido, A ;
Herrero-Vanrell, R ;
Molina-Martínez, IT ;
Pastoriza, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 279 (1-2) :33-41
[10]  
FRANCE CP, 1994, J PHARMACOL EXP THER, V270, P992